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Background: The evidence regarding oral contraceptives and its effectiveness with concomitant ingestion of
antibiotics is conflicting. Until evidence becomes clearer, patients should be aware of this possible interaction. The
aim of this study was to assess the knowledge and the source of information about this interaction in GP patients
in Austria.
Methods: Within the framework of the APRES study, 20 Austrian GPs were purposefully selected from among a GP
research network and were asked to recruit 200 patients each. The patient cohort was asked to complete a
questionnaire. Subsequent analysis included descriptive statistics, statistical tests and logistic regression models.
Findings: Overall, 3280 questionnaires could be used for analysis. Of these, 29.7 % (n = 974) of patients
acknowledged an awareness of the interaction of antibiotics with OCPs. Women under the age of 46 years
acknowledged this interaction in 52.3 % of cases. Positive associations for the belief in an existing interaction in
women were identified with age (OR 2.2) and having read the package inserts (OR 1.6). Further, belief was
recognized in males based on age (OR 2.5) and tertiary education (OR 2.0). The main source of information
regarding antibiotics was the GP (55.9 %).
Conclusions: Less than one-third of all participants and half of the women in the reproductive age acknowledged
an interaction between antibiotics and OCPs. Since the GP is the main source of information, this finding depicts a
large potential for knowledge transfer within the primary health care setting. A multifaceted strategy is needed at
both the population and the GP level to improve awareness and to address these educational gaps.
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AustriaIntroduction and background
Oral contraceptive pills (OCP) and antibiotics are both
among the most frequently prescribed drugs in the
United States and Europe, including Austria [1, 2]. How-
ever, current evidence regarding the intake of antibiotics
and any potential impact on the effectiveness of the
OCP is conflicting. While a large epidemiological U.S.
study concluded that no association between concomitant
antibiotic use and the risk of breakthrough pregnancy
among OPC users could be found [3], a case-crossover* Correspondence: kathryn.hoffmann@meduniwien.ac.at
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unless otherwise stated.study from the Netherlands reported that a relationship
could be likely [4]. Further, results of pharmacokinetic and
clinical studies appear to be contradictive: in some studies
a possible effect of impairment of the enterohepatic circu-
lation by contraceptives and antibiotics was witnessed [5,
6], while in others oral antibiotics did not affect the
pharmacokinetics of OCPs (with the exception of rifam-
pin) [7]. Dickinson et al. reported that individual patients
on certain antibiotics did show substantial decreases in
the plasma concentrations of ethinyl estradiol, although
no systematic interaction between antibiotics and OPCs
could be found. As it is difficult to identify these women
in advance of complications, the authors recommended a
cautious approach [8]. Until the evidence is clear, thisral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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should continue to be included among the package inserts
of both antibiotics and OCPs.
Additionally, recent health policy publications have
recognized a prominent role for “health literacy” as the
“people’s knowledge, motivation and competences to ac-
cess, understand, appraise, and apply health information
[…] [9]”. Considering this, citizens should be aware of
conflicting fields in order to be able to appraise potential
risk for their own situation and to actively participate in
decision-making. Particularly, this is of high relevance in
the field of family planning because of the social and
psychological consequences of unintended pregnancies
for the mother, father, and the child [10, 11].
The knowledge about drug interactions has been ob-
served as low among the general population, although,
adverse drug events are the most common type of injury
occurring in patients [12–15] and the public has
expressed interest in greater awareness of these medica-
tions [14].
The present study - intended to function as an add-on
to the European APRES project [16]- aimed for a two
goal approach:
First, we aimed to assess the knowledge about possible
drug interactions in both men and women. Inclusion of
both genders was an important element, as both might
fill the role of parent, partner or friend, and may
influence women that take OCPs. Further, it is
recognized that social and cultural context has a high
impact on individuals and their willingness to learn
about or change their situation if offered the intrinsic
or extrinsic opportunity to do so [9, 17]. Cultural and
social beliefs and norms are often driven by societal
expectations, and can be particularly influenced by the
literacy of a husband, more than the knowledge of a
woman, in patriarchal cultures [18, 19].
The second aim was to analyse possible social and
cultural factors associated with patient knowledge.
Further, the main source of a given patient’s
information on knowledge about antibiotic interactions
as well as other possible influencing factors from the
GPs’ side were assessed.
Methods
Design
We performed an add-on study to the European APRES
project, a cross-sectional study that lasted from Novem-
ber 2010 until July 2011 [16]. More detailed information
concerning the design and the overall aim of the APRES
project are described in the publication by van Bijnen
et al. [16].
In Austria, a stratified sample of 20 purposefully se-
lected GPs was recruited via electronic invitationsthrough the Austrian Society of General Practice, the re-
search network of the Department of General Practice at
the Medical University of Vienna and personal contacts.
Each GP was asked to complete a short questionnaire
(“GP questionnaire”) concerning demographic variables
and the location of their practice. The GPs were asked
to recruit 200 consecutive patients from within their
practices during consultation hours. After signing an
informed consent form, patients were asked to complete
two questionnaires (“patient questionnaires”). Following
the APRES study protocol, patients younger than four
years, patients with infections or symptoms of an infect-
ive disease, patients treated with antibiotics within the
last three months, patients with terminal diseases, pa-
tients with immunosuppressive diseases or treatments,
patients who had been hospitalized within the last three
months and patients living in a nursing home were
excluded. In addition, for this analysis we included only
patients aged 12 years and older because the drug inter-




For this add-on study, an additional 12 item question-
naire was developed which was handed out alongside
the APRES patient questionnaire. In this questionnaire,
six questions covered knowledge about antibiotics, one
of which specifically addressed the antibiotic and OCP
interaction. The detailed add-on questions can be viewed
in a separate publication [20].
The question related to the antibiotic to OCP inter-
action is as follows: “Taking antibiotics can lead to inef-
fectiveness of contraception by the Pill.” There were
three response options: “yes”, “no” and “I don’t know”.
Later, for the binary logistic regression model this vari-
able was dichotomized into the answer option “yes”, ver-
sus the other two options. The interaction variable was
defined as a dependent variable.
The demographic data requested and relevant for this
analysis included the educational level and country of
origin of the patients. Highest educational level accom-
plished was assessed in three categories: primary educa-
tion, secondary education (apprenticeship or secondary
school) and tertiary education (university or any further
education). Migration status was assessed with the ques-
tion “What is your country of origin?” This variable was
stratified within three categories: Austria, other Euro-
pean Union (EU) 28 countries as well as Norway and
Switzerland (EU28+), and “all other countries”. Finally,
the main source of information related to antibiotics was
asked: GP, specialist, pharmacy, media, internet, package
insert, own estimation or relatives and friends. Respon-
dents were instructed to mark only one out of the eight
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then clustered into GP, specialist/pharmacy, media/inter-
net/relatives/friends/own estimation, and package insert.
In addition, other socio-demographic data from the
APRES patient questionnaire, such as gender and age of
the patients, was taken into account. The age of patients
was clustered into seven groups, namely those up to the
age of 25, those aged 26–35 years, 36–45 years, 46–55
years, 56–67 years, 66–75 years and participants aged
76 years and older. Moreover, the age of the participants
was dichotomized into an age group of persons younger
than 46 years of age and those older than 46 years of
age. This dichotomy was assessed to identify women in
the reproductive age and to have a direct comparison
with the male group of the same age.GP questionnaire
From the GP questionnaire the gender and location (urban
or rural area) of the GPs was used for analysis. Additionally,
the identification code of the GP offices was used for the
regression model to adjust for the clustering of patients in
GP practices.
The demographic variables from both patient and GP
questionnaire were defined as explanatory variables.Data analyses
First, the sample of patients and GPs were characterized
using descriptive methods. Tests for subgroup analyses
were performed by means of cross-tabs. The statistical
test applied was the Chi-Square Independency test. If an
independency could not be proven, the z-test, including
the Bonferroni method for multiple testing, was applied
to identify those sub-groups which were dependent. The
significance level for all calculations was p < 0.05 and the
confidence interval 95 %.
A multivariable logistic regression model was employed
for the women’s and men’s group separately in which the
interaction knowledge variable “yes” was defined as the
dependent variable. All demographic variables and the GP
identification code variable were taken into the model
simultaneously. The results of all regression models are
presented as odds ratios with 95 % confidence intervals.
Nagelkerkes’ R2 (logistic regression models) is presented
as a measure of model-fit.
SPSS Statistics 20.0 was used for all statistical analyses.Ethical considerations
For those participants younger than 18 years of age, the
parent and adolescent each completed written informed
consent forms separately. The study and analysis was ap-
proved by the Ethics Committee of the Medical University
Vienna (EC # 568/2010).Results
Sample and source of information
Overall, 3280 questionnaires could be used for analysis.
A detailed description of GPs and patients included in
this study has been published [20]. The patients included
were 56.4 % women; the primary level of education was
49.0 %, while the secondary and tertiary levels were
37.3 13.7 % respectively. The country of origin was
found to b86% Austria and 6.0 % EU28+ country. Age
groups were distributed as follows: age group 12–25
years 11.7 % females (f ) and 13.0 % males (m), age
group 26–35 years 15.1 % f and 13.7 % m, age group
36–45 years 18.3 % f and 15.6 % m, age group 46–55
years 19.4 % f and 21.4 % m, age group 56–65 years
14.0 % f and 16.9 % m, age group 66–75 years 15.2 % f
and 14.6 % m, and age group 76 years and older 6.3 % f
and 4.8 % m. The participating GPs were 30.0 %
women and the location of the office was 55.0 % in
rural areas.
Regarding the source of information about antibiotics,
55.9 % indicated that this came from the GP, 3.6 % from
specialists/pharmacy, and 28.3 % from media/internet/
friends/relatives/ neighbours/own estimation. The final
12.0 % related that the package insert was the primary
source of information about antibiotics.
Antibiotics- OCP interaction
When questioned about awareness of interaction be-
tween antibiotics and OCPs, 29.7 % (n = 974; f 31.1 %
vs. m 19.9 %; p < 0.05) of participants marked “yes”,
while 9.0 % (n = 296; f 10.2 % vs. m 7.6 %; p < 0.05)
indicated “no”, 59.3 % (n = 1946; f 51.4 % vs. m
69.7 %;p < 0.05) “not known”, and 2.0 % (n = 64; f 1.3 %
vs. m 2.7 %; p < 0.05) of the participants did not re-
spond to the question.
Within the group of the women in the reproductive age
(those below 46 years of age) (n = 801), 52.3 % marked
“yes”, 11.8 % “no” and 35.9 % marked “don’t know/no
answer”. In contrast, within the group of women 46 years
and older (n = 977) 24.4 % marked “yes”, 9.0 % indicated
“no and 66.6 % marked “don’t know/no answer”. Males
younger than 46 years of age (n = 586) marked “yes”
30.4 % of the time, while 10.1 % of this same group
marked “no” and the final 59.6 % indicated “don’t know/
no answer”. Finally, among men 46 years and older (n = 794)
12.1 % indicated “yes”, 5.9 % “no” and 82.0 % marked “don’t
know/no answer”.
Table 1 shows the distribution of responses to the
question on drug interaction in relation to the patients’
demographic variables, the sex of the GP, the location of
the GP office, and the source of information related to
antibiotics for women. Table 2 shows the same results
for male patients. In addition, statistically significant
differences for subcategories of the variables are shown.
Table 1 Female subgroup analysis related to the antibiotics-OCP interaction knowledge
Yes (%) No (%) Dont know/no answer (%) p-value
Sex Age group Categories Subcategories (n)
F <46 years Age groups (years) <0.001
−25 (n = 210) 58.1 13.8 28.1
26-35 (n = 270) 58.9 10.4 30.7
36-45 (n = 325) 43.1 11.7 45.2
46+ years <0.001
46-55 (n = 345) 36.8 12.2 51.0
56-65 (n = 252) 23.8 9.9 66.3
66-75 (n = 269) 15.6 5.2 79.2
76+ (n = 111) 8.1 6.3 85.6
<46 years Educational level 0.029
Primary (n = 299) 50.8 10.0 39.1
Secondary (n = 354) 55.6 10.5 33.9
Tertiary (n = 148) 46.6 18.9 34.5
46+ years 0.013
Primary (n = 532) 24.8 7.3 67.9
Secondary (n = 318) 23.9 8.8 67.3
Tertiary (n = 112) 23.2 17.9 58.9
<46 years Country of origin <0.001
Austria (n = 678) 55.9 10.8 33.3
EU 27 + (n = 51) 41.2 17.6 41.2
Others (n = 74) 27.0 17.6 55.4
46+ years 0.274
Austria (n = 857) 24.5 8.5 67.0
EU 28+ (n = 55) 16.4 14.5 69.1
Others (n = 64) 29.7 10.9 59.4
<46 years GP gender 0.015
Female GP (n = 207) 44.4 11.6 44.0
Male GP (n = 598) 55.0 11.9 33.1
46+ years 0.080
Female GP (n = 338) 20.1 9.5 70.4
Male GP (n = 639) 26.6 8.8 64.6
<46 years Location GP office <0.001
Urban (n = 340) 44.7 15.3 40.0
Rural (n = 465) 57.8 9.2 32.9
46+ years 0.002
Urban (n = 481) 20.2 11.2 68.6
Rural (n = 496) 28.4 6.9 64.7
<46 years Source of information 0.580
GP (n = 338) 50.9 10.1 39.1
Specialist/pharmacy (n = 26) 57.7 11.5 30.8
Media/Internet/Friends/Own (n = 157) 52.9 11.5 35.7
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Table 1 Female subgroup analysis related to the antibiotics-OCP interaction knowledge (Continued)
Package insert (n = 123) 61.0 9.8 29.3
46+ years 0.035
GP (n = 496) 19.2 8.9 72.0
Specialist/pharmacy (n = 25) 16.0 8.0 76.0
Media/Internet/Friends/Own (n = 212) 26.4 8.5 65.1
Package insert (n = 97) 29.9 14.4 55.7
Significance at a significant level of p < 0.05
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knowledge and demographic factors
Table 3 illustrates the results of the adjusted regression
models for the group of women below as well as the
group over 46 years of age, and the associations between
their knowledge about the drug interaction and patient-
factors, GP-factors, and source of information. Similarly,
Table 4 shows these findings for males.Discussion
This study shows that less than one third of all partici-
pants (29.7 %) are aware of a possible interaction be-
tween antibiotics and OCPs.
This finding is worrying, particularly against the back-
ground of recent literature recommending to inform the
population of possible interactions between antibiotics
and OCPs. Further, the intake of both antibiotics and
OPCs is high in Austria: in the year 2010, the antibiotic
consumption in Austria was approximately 15 DDD per
1000 inhabitants per day and 60.7 % of women between
15 and 30 years, and 28.6 % of women between 30 and
45 years took OCPs [2].
On the other hand, however, it is remarkable that this
knowledge exceeds that for the well-established thera-
peutic spectrum of antibiotics described in another pub-
lication, where only 28.1 % of individuals were aware
that antibiotics do not kill viruses [20].Interaction knowledge
Considering the different patient groups, it is not sur-
prising that about half of the group of women below
46 years of age indicated an awareness of possible inter-
actions between antibiotics and OCPs (52.3 %). This is
the group with the most contact to OCPs and, therefore,
has the highest likelihood of previous exposure to infor-
mation about this interaction. This finding is similar to
the results from a 2002 U.K. study in which 64 % of
OCP taking women aged 18 to 24 years answered that
they knew about an interaction between antibiotics and
OCPs [21].
Evaluating the age groups further, it became clear that
those women aged 26 to 35 most often recognized this
interaction (58.9 %). However, with every ten yearincrease in age, nearly 10 % fewer women expressed
awareness of a possible interaction (Table 1).
Knowledge of this interaction was recognized in less
than one third of males (30.4 % for males aged less than
46 years) and far less (12.1 %) in the group of men above
the age of 46 (Table 2). Similar to responses in the
female groups, the age of males does show impact on
the likelihood of knowledge about interaction, with the
youngest men most often aware of this possible inter-
action (37.2 %). This finding was consistent in the multi-
variable regression models in which younger age was
positively associated with the knowledge in all patient
groups (Tables 3 and 4).
In comparison to all other age groups, only younger
males with tertiary education demonstrated more know-
ledge in both the univariate (38.8 %, Table 2) and the
multivariable models (OR 2.0, Table 4). This might re-
flect that this group is, potentially, more involved in the
process of family planning at this stage of their lives and,
eventually, take a more participative and responsible role
in family planning [22]. However, this would warrant
further study.
On the other hand, the youngest group of women had
the most “no” responses to the question of awareness of
interaction, even when compared to the respective male
subgroup (13.8 %). Only women with tertiary education
marked “no” more often (17.9 %, Table 1). The findings
of a German pilot-study point in a similar direction:
while most women were confident of being knowledgeable
about OCPs, many were unaware of their knowledge
gaps [23]. Explanations for this unexpected result could
be that the main OCP users were still too young to have
completed their third level of education. Further, it was
considered that women with tertiary education could
possibly take OCPs less often, as they are commonly
over the age of 35, which is a risk factor for taking less
effective contraceptive methods [18, 24, 25]. In contrast,
this finding could be due to a bias, as explained in the
introduction section, the scientific evidence about the
interaction effect is conflicting. Participants who know
about this could have responded “no” because they have
a more detailed knowledge of the circumstances of this
issue. Regardless, more in-depth analysis with qualitative
or quantitative methods, including a further question
Table 2 Male subgroup analysis related to the antibiotics-OCP interaction knowledge
Yes (%) No (%) Dont know/no answer (%) p-value
Sex Age group Categories Subcategories (n)
M <46 years Age groups (years) 0.001
−25 (n = 180) 37.2 11.7 51.1
26-35 (n = 190) 33.7 11.6 54.7
36-45 (n = 216) 21.8 7.4 70.8
46+ years 0.001
46-55 (n = 293) 18.4 7.2 74.4
56-65 (n = 235) 9.8 6.0 84.3
66-75 (n = 200) 8.0 5.5 86.5
76+ (n = 60) 4.5 1.5 93.9
<46 years Educational level 0.035
Primary (n = 248) 24.2 12.1 63.7
Secondary (n = 257) 33.9 9.7 56.4
Tertiary (n = 80) 38.8 5.0 56.3
46+ years 0.071
Primary (n = 454) 11.2 4.4 84.4
Secondary (n = 239) 11.3 7.5 81.2
Tertiary (n = 93) 17.2 9.7 73.1
<46 years Country of origin
Austria (n = 486) 31.3 9.3 59.5
EU 27 + (n = 36) 36.1 11.1 52.8
Others (n = 61) 21.3 16.4 62.3
46+ years 0.314
Austria (n = 686) 12.2 5.8 81.9
EU 27 + (n = 51) 17.6 5.9 76.5
Others (n = 51) 3.9 5.9 90.2
<46 years GP gender 0.914
Female GP (n = 116) 31.9 9.5 58.6
Male GP (n = 470) 30.0 10.2 59.8
46+ years 0.154
Female GP (n = 214) 8.4 6.1 85.5
Male GP (n = 580) 13.4 5.9 80.7
<46 years Location GP office 0.746
Urban (n = 271) 31.4 10.7 57.9
Rural (n = 315) 29.4 9.5 61.0
46+ years 0.007
Urban (n = 322) 8.1 7.5 84.5
Rural (n = 472) 14.8 4.9 80.3
<46 years Source of information 0.242
GP (n = 233) 29.6 8.2 62.2
Specialist/pharmacy (n = 21) 38.1 23.8 38.1
Media/Internet/Friends/Own (n = 167) 30.5 9.6 59.9
Package insert (n = 55) 25.5 9.1 65.5
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Table 2 Male subgroup analysis related to the antibiotics-OCP interaction knowledge (Continued)
46+ years 0.002
GP (n = 394) 14.5 2.3 83.2
Specialist/pharmacy (n = 23) 4.3 4.3 91.3
Media/Internet/Friends/Own (n = 209) 12.0 9.6 78.5
Package insert (n = 45) 4.4 4.4 91.1
Significance at a significant level of p < 0.05
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benefit to better explain this result.
In addition, women below 46 years of age from other
countries marked “yes” significantly less often than
women from Austria or EU28+ countries with only
27.0 % doing so (Table 1). In the multivariable model,
those patients originating from another country showed
a negative association with an OR of 0.2 compared to
Austrians (Table 3). This is a common finding in epi-
demiological studies related to health knowledge and in
health literary [26, 27]. One reason could be the obstacle
inherent in speaking and understanding the language in
the respective country. To improve the situation, it
would be necessary to provide target-group specific in-
formation, for example by inventing and implementing
picture-based and computer-tailored educational pro-
grams [28].Table 3 Results of the adjusted regression model for women
Wo
Category Subcategory OR
Educational level Primary 1.0
Secondary 1.2
Tertiary 1.1
Country of origin Austria 1.0
EU 27 + EFTA 0.6
Others 0.2




GP gender Female 0.8
Male 1.0
Location of GPoffice Urban 0.7
Rural 1.0





Adjusted for GP cluster (GP identification code)
Significant at a level of p <0.05When asked for the source of information on anti-
biotic – OCP interaction, 55.9 % of all patients marked
the GP. Younger men and both younger and older
women who marked the GP as their main source of in-
formation had the lowest number of “yes” answers com-
pared to the other information groups (Table 1 and 2).
After adjustment in the multivariable regression model,
a positive association could only be found for reading
the package insert for younger women (OR 1.6) and
information via media/internet/friends for older women
(OR 1.6) compared to the information via a GP (Table 3).
This finding depicts a large potential for knowledge
transfer within the primary health care setting. The re-
sult might be due to the lack of clear scientific evidence
as well as the resulting uncertainty of GPs on how to ad-
vise their patients. However, it is known that the overall
knowledge about antibiotics in Austria compared tomen <46 years Women 46 years and older
CI 95 % p-value OR CI 95 % p-value
1.0
0.8-1.7 0.331 1.1 0.8-1.6 0.580
0.6-1.7 0.961 0.8 0.4-1.4 0.391
1.0
0.3-1.2 0.122 0.6 0.3-1.4 0.251
0.1-0.5 <0.001 1.4 0.7-2.7 0.353
1.2-2.6 0.004 6.0 2.7-13.7 <0.001
1.5-3.2 0.001 3.5 1.5-8.2 0.004
2.4 1.1-5.7 0.042
1.0
0.5-1.3 0.339 0.8 0.5-1.2 0.291
1.0
0.5-1.1 0.105 0.8 0.5-1.2 0.291
1.0
1.0
0.6-3.5 0.380 0.7 0.2-2.1 0.516
0.8-1.9 0.308 1.6 1.1-2.3 0.030
1.1-2.6 0.031 1.5 0.9-2.6 0.103
0.117 0.097
Table 4 Results of the adjusted regression model for men
Men 45 years and younger Men 46 years and older
Category Subcategory OR CI 95 % p-value OR CI 95 % p-value
Educational level Primary 1.0 1.0
Secondary 1.5 0.9-2.3 0.088 1.1 0.6-1.8 0.955
Tertiary 2.0 1.1-4.0 0.038 2.4 1.1-5.1 0.023
Country of origin Austria 1.0 1.0
EU 27 + EFTA 1.6 0.7-3.5 0.283 0.9 0.3-2.2 0.820
Others 0.5 0.2-1.0 0.053 0.3 0.1-1.4 0.140
Age groups (years) −25/46-55 2.5 1.5-4.2 0.001 3.7 1.1-12.5 0.037
26-35/56-65 1.9 1.2-3.2 0.012 2.5 0.7-8.7 0.164
36-45/66-75 1.0 1.9 0.5-6.8 0.340
/76+ 1.0
GP gender Female 1.2 0.7-2.0 0.624 1.1 0.5-1.9 0.963
Male 1.0 1.0
Location of GP office Urban 0.9 0.6-1.6 0.995 0.4 0.2-0.8 0.009
Rural 1.0 1.0
Source of information GP 1.0 1.0
Specialist/pharmacy 1.3 0.5-3.4 0.623 0.3 0.1-2.5 0.277
Media/Internet/Friends/Own estimation 1.1 0.7-1.6 0.913 0.6 0.4-1.3 0.295
Package insert 0.9 0.5-1.8 0.753 0.3 0.1-1.1 0.069
Nagelkerkes R2 0.087
Adjusted for GP cluster (GP identification code)
Significant at a level of p <0.05
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some improvement observed between 2010 and 2013. It
has been suggested that, until evidence is further clari-
fied, women should be informed about this possible
interaction with OCPs. Therefore, GPs should consider
the possibility of interaction each time they choose to
prescribe an antibiotic [21, 30, 31]. In a retrospective
analysis, Mastrantonio et al., for example, showed that
out of 100 female patients aged 15–39 to whom antibi-
otics were prescribed, the concomitant use of contracep-
tion was documented in only 3 % [32].
Our findings could suggest a large potential for im-
provement in primary care for knowledge transfer re-
garding drug interactions, as patient knowledge is low
and the consequences are dangerous [12–15]. A Norwe-
gian study, for example, described that older patients de-
sire counselling on drug interactions [14]. Despite this,
counselling is recognized as a time consuming task and
should be acknowledged in the financing system of GPs.
Strengths and limitations
One strength of this analysis is that patient-related factors
were taken into consideration, as well as the addition of
possible physician-related factors such as gender, location
of office, and the main source of information for patients.
The large sample size and the provision for differentmigration and age groups and educational levels similar to
the Austrian population are further strengths of this study.
Compared to the demographic distribution of all GPs with
offices in Austria in the year 2011 (n = 6527; males 60.7 %,
females 39.3 %, mean age 52.5 years) the numbers of the
GPs in the sample size are similar. Moreover, compared
with the Austrian population in the year 2011 (51.2 %
females; mean age 43.9 years), the gender distribution of
the study sample is similar; however, the mean age of the
sample is higher.
The recruitment strategy of both GPs and patients is a
limitation, although, it is a usual approach in General
Practice research [33]. Due to the fact that the participa-
tion of GPs and patients was on a voluntary basis and
not based on a randomized sample, it may be speculated
that only those GPs and patients interested in the topic
of antibiotic resistance participated in the study. This
would lead to an over-estimation of the real knowledge.
Moreover, GPs did not identify how many patients
refused to take part in this study.
Another important limitation is that we did not survey
the prevalence of OCP intake among the participants
and, therefore, no conclusions about the specific know-
ledge of the OCP user group can be drawn. However,
this was not an aim of this study. Another methodological
drawback is the fact that this study is cross-sectional and,
Hoffmann et al. Reproductive Health  (2015) 12:43 Page 9 of 10therefore, of limited explanatory power. Furthermore, re-
sults are based on descriptive and self-reported survey
data. A further limitation is that the questionnaires were
available in German only. Lastly, the fact that the source
of information was surveyed at the GP offices could have
led to a selection bias, due to participants that marked the
GP as their main source of information.Conclusion
Experts recommend informing OCP users of the poten-
tial for an interaction between antibiotics and OCPs and
the risk on the effectiveness of OCPs. Clinicians are en-
couraged to advise female patients on the use of add-
itional measures of birth control during and up to one
week after antibiotic therapy [34]. Despite this, the
knowledge about the possibility of an interaction is low
in Austria. On a population level this knowledge could
be taught in schools or via target-group specific infor-
mation campaigns using picture-based counselling strat-
egies to reach those with the most need. On the health
care level, GPs could be an important source of infor-
mation, at the very least for women taking OCPs. It is
hoped that evidence-based guidelines regarding this
controversy will become available [34] to support GPs
in their counselling as well as patients in their health
literacy. For that, GPs should document the use of
contraception by their patients; when prescribing anti-
biotic medications in patients with concomitant OCP
use GPs should be aware of this and should inform the
patients.
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